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Abstract
Dendritic cells (DCs) constitute a heterogeneous group of antigen-presenting leukocytes important in activation of both
innate and adaptive immunity. We studied the gene expression patterns of DCs incubated with reagents inducing their
activation or inhibition. Total RNA was isolated from DCs and gene expression profiling was performed with oligonucleotide
microarrays. Using a supervised learning algorithm based on Random Forest, we generated a molecular signature of
inflammation from a training set of 77 samples. We then validated this molecular signature in a testing set of 38 samples.
Supervised analysis identified a set of 44 genes that distinguished very accurately between inflammatory and non
inflammatory samples. The diagnostic performance of the signature genes was assessed against an independent set of
samples, by qRT-PCR. Our findings suggest that the gene expression signature of DCs can provide a molecular classification
for use in the selection of anti-inflammatory or adjuvant molecules with specific effects on DC activity.
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Introduction
Dendritic cells (DCs) are bone marrow-derived cells present in
all lymphoid and non lymphoid organs. They play a role in
immune regulation, inducing tolerance and preventing autoim-
munity, inducing anti-tumor immunity and protecting against
infectious agents. DCs constitute a heterogeneous group of cells
with different origins (both myeloid and lymphoid), anatomic
locations, cell surface phenotypes and functions. Within the
different DCs subtypes, myeloid DCs are also the most efficient
antigen-presenting cells in the induction of naive, memory, effector
and regulatory T-cell responses [1–3].
DCs have several pattern recognition receptors (such as Toll-
like receptors). During infection or inflammation, these receptors
interact with microbe-associated molecules (such as LPS, bacterial
DNA and double-stranded RNA), resulting in DC activation [4,5].
Endogenous TLR ligands are also released in conditions of
inflammation, such as cell injury, and induce similar activation
programs [6,7]. These programs affect various DC functions, such
as migration to draining lymph nodes for antigen presentation,
costimulation and the production of a specific cytokine profile
determining the type of T-cell response to be developed. This
process is known as maturation and it enables DCs to initiate and
direct the acquired immune system (B and T cells) and, ultimately,
to mount an antigen (Ag)-specific response [8].
Global transcriptomic analysis has recently been shown to be a
powerful approach yielding new insight into the biology of specific
cell subsets or tissues, by providing information about their specific
gene expression programs [9–12]. Moreover, the analysis of
genome-wide expression profiles is now a widely used technique
for the identification of diagnostic markers of various disease states,
outcomes, or responses to treatment [13–17]. Markers are selected
by scoring each individual gene on the basis of the extent to which
its expression pattern discriminates between different classes of
disease or between cases and controls. The disease status of new
patients is predicted with classifiers tuned to the expression levels
of the marker genes. One potential problem with expression-based
classification is that cellular heterogeneity within tissues and
genetic heterogeneity between samples may decrease the discrim-
inatory power of individual genes in complex diseases [18,19]. As
DCs are involved in various diseases involving the immune system,
from inflammatory diseases to cancer, the identification of
molecular markers in DCs specific to inflammation is of potential
clinical and pharmaceutical value.
A number of time course and end points studies of the DCs
activation process have been published to describe the dynamic
process of interaction among gene transcripts that are important
for controlling many of the observed changes that occur during the
process of activation/maturation [20–28]; however, these studies
utilize analysis methods for differential gene expression and do not
take into account class prediction methods. We applied a
classification algorithm to derive a list of genes able to predict
the DCs activation state. In this study, we identified a genetic
signature of inflammation in mouse DCs. We chose to study mice,
because they are widely used in models of many immunological
diseases. These findings may lead to the identification of a
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9404prospective signature of inflammation and should increase our
understanding of the biological processes underlying chronic
inflammatory diseases.
Results
Sample Selection and Processing
In total, 115 samples were analyzed to develop a prognostic
molecular assay of DC activation. Seventy-seven arrays were used
for the training set and 38 were used for the testing set. We
analyzed different samples of the DC line D1 [29] treated with
inflammatory stimuli including bacteria (Listeria monocytogenes),
helminths (Schistosoma eggs), protozoa (Leishmania promastigotes)
and TLR ligands (LPS, poly I:C and zymosan) and samples of D1
cells treated with dexamethasone, Schistosoma SLA and Leishmania
amastigotes, all of which are known to downregulate the
inflammatory response [30,31]. The microarray data used were
either generated in this study or derived from previous
experiments [23,30,32]. Table 1 describes the sample dataset
used in this study. We amplified total RNA and hybridized it to an
Affymetrix mouse MG-U74Av2 GeneChip oligonucleotide micro-
array containing 12,488 probe sets. The resulting microarray
signal intensities for all 12,488 probe sets were normalized and the
background was subtracted.
Multivariate Analysis Reveals the Existence of an
Inflammatory State for Dendritic Cells
Principal component analysis (PCA) makes it possible to
visualize correlations in datasets by compressing information into
a small number of dimensions. PCA was carried out on the data
for DCs treated with stimuli inducing activation via various
receptors, including the Toll-like receptors. Projection of the
samples onto a plane corresponding to the first two dimensions
derived from PCA resulted in a clear separation along the first
dimension (Figure 1). Control and experimental samples treated
with anti-inflammatory stimuli were projected toward positive
values of the first dimension and samples with signs of activation
were projected toward negative values. The PCA data suggest that
DCs in different functional states could be separated on the bases
of differences in inflammatory stimulation and that the inflamed
samples could be isolated from all the other stimuli in a typical
two-classes partitioning.
Data Analysis Strategy for the Selection of Classifier
Genes
We carried out a step-wise analysis to determine whether it was
possible to select a gene expression signature of inflammation: (a)
an expression index was calculated with RMA [33]; (b) sample
classification: genes capable of discriminating between the two
groups were identified by comparing groups of samples in the
inflammatory group with those in the non inflammatory group
(training set); (c) independent validation of classifier genes: the
genes selected were used to classify an independent group of
samples (testing set); (d) validation of the genetic signature by
quantitative RT-PCR (qRT-PCR) on independent DCs samples
prepared with different stimuli. The procedure used for the
selection and preparation of microarrays is shown in Figure S1.
Transcriptional Signatures Discriminate between
Inflammatory and Steady State Cellular Phenotypes
Raw intensity values from microarray hybridization were
normalized with the robust multiarray average in the R-package
for statistical computing (available at www.R-project.org). A
random forest classification model was built from a training set
(50 observations in conditions of inflammation, 27 observations in
non inflammatory conditions) obtained from the genome-wide
gene expression analysis of DCs incubated with different stimuli.
All the samples were assigned to training or testing sets: two thirds
of the samples (n=77) were assigned to the training sets, the
remaining third being assigned to testing sets (n=38; Figure S1).
The results obtained for the untreated samples and those treated
with non inflammatory stimuli were very similar and these two
groups of samples were therefore considered to belong to the same
class (data not shown). This approach resulted in the identification
of 54 genes distinguishing accurately between the two classes of
samples, as demonstrated by analysis with the testing set (data not
shown; Table 2). The molecular signature was illustrated with a
heat map based on Euclidean distance (Figure 2). We identified 18
genes downregulated by inflammation and 36 upregulated by
inflammation. Unsupervised clustering analysis confirmed the
robustness of the set of genes identified, with very clear distinction
between samples treated with and without inflammatory stimuli
(Figure 2). Gene Ontology was used to classify the modulated
genes in terms of function. The genes selected encoded proteins
involved mainly in the immune system process (44%), cell
differentiation (44%), cell death (30%), and regulation of biological
process (55%), as shown in Table 3.
The downregulated genes were found to encode proteins
involved in the biological pathways of cell division (Ccnb2,
Kif20a, Cdc20), lipid metabolic process (Daglb, Elovl6, Lta4h,
Sgpp1), defense response (hdac5, Il1rl1, Il18r1, Lta4h), and
metabolic processes (Txndc16, Hdac5, Il1rl1, Daglb, Lta4h,
Tep1, Sgpp1, H2-DMa, Eif4ebp2, Man2b1, Elovl6, Znrf2,
Cdc20). Two of these genes, Tm7sf3 and Tspan8, could not be
functionally classified (Table 4). The upregulated genes encoded
proteins involved in the immune system response (Psme2, Cd40,
Ccl22, Il1b, Sqstm1, Tap1, Il6, Il12b, Ifit1, Ccr7, Irf8, Isg15,
Nfkbia, Nfkb1, Stat5a, Cdkn1a), cell death (Traf1, Stat5a, Sqstm1,
Il6, Nfkb1, Cd40, Cdkn1a, Gadd45b, Tnfrsf1b, Serpinb9, Daxx),
regulation of biological processes (Nfkbia, Traf1, Stat5a, Il1b,
Clic4, Nfkbiz, Icam1, Gadd45b, Il12b, Irf8, Tnfrsf1b, Serpinb9,
Dnajb6, Sqstm1, Il6, Nfkb1, Cd40, Cdkn1a, Daxx, Gnai3,) and
cell differentiation (Nfkbia, Skil, Traf1, Stat5a, Clic4, Gadd45b,
Table 1. Characteristic of the Microarray Data Set used.
Cell Type Stimulus Nu of Arrays Class Ass
DC D1 None 14 Non Inflamm
DC D1 DEX 6 Non Inflamm
DC D1 Leishmania Ama 8 Non Inflamm
DC D1 Shistosoma SLA 8 Non Inflamm
DC D1 CpG 10 Inflamm
DC D1 Leishmania Pro 8 Inflamm
DC D1 Listeria EGD 20 Inflamm
DC D1 LPS 8 Inflamm
DC D1 PAM3Cys 10 Inflamm
DC D1 Poly I:C 10 Inflamm
DC D1 Shistosoma Eggs 8 Inflamm
DC D1 Zymosan 15 Inflamm
Total 115
doi:10.1371/journal.pone.0009404.t001
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Cdkn1a, Daxx).
Real-Time Reverse Transcriptase (RT)-PCR Validation of
Microarray Observations
Despite the accuracy of the classifier for random forest-based
class assignment in a test set of DC samples, the mean expression
index of transcripts was low. We therefore performed qRT-PCR
to confirm the relative expression levels recorded for the DC
samples with Affymetrix technology. We used the 18s rRNA gene
as a housekeeping gene for the normalization of target gene
expression. We prepared independent DC line D1 samples by
treating the cells for 24 h with known signals, such as 10 mg/ml
LPS, 20 mg/ml Poly I:C and 500 ng/ml zymosan, and with
10
28 M dexamethasone, 10
28 M vitamin D and 50 ng/ml IL10,
which are known to have anti-inflammatory activity [34–38]. All
the RNA samples in the study were converted to cDNA using the
same reverse-transcription cocktail and procedure. The pattern of
gene expression observed on qRT-PCR confirmed the microarray
data. We assessed the predictive value of genes by calculating the
median levels of expression for that gene in the known
inflammatory and anti-inflammatory samples and then determin-
ing the mean expression level for the gene between the two classes.
These threshold values were used to determine whether, for a
given stimulus, the level of expression of the gene could be used to
assign the sample to the correct class. We therefore subjected all
the genes to the same test, under different stimulation conditions.
A score of 1 was assigned if the expression level exceeded the mean
expression value for an upregulated gene for a sample to be
inflammatory or was less than the mean value for a sample to be
anti-inflammatory. For repressed genes, we applied the opposite, a
score of 1 was assigned if the expression level was less than the
mean expression value for a sample to be inflammatory or was
more than the mean value for a sample to be anti-inflammatory. A
score of 0 was awarded in all other cases (Figure S2). Poly I:C
stimulation was correctly classified by 94% (51/54) of the genes,
whereas LPS and zymosan stimulations were correctly classified by
89% (48/54) and 85% (46/54) of the genes, respectively. As
predicted, dexamethasone was the best anti-inflammatory reagent,
correctly classified by 100% (54/54) of the genes. IL10 and
vitamin D were identified as anti-inflammatory stimuli by 96%
(52/54) and 89% (48/54) of the genes, respectively (Figure 3).
Vitamin D upregulated Il1b, Rab20, Nfkbia, Nfkbiz and Skil.
These genes are upregulated by TLRs ligands (Figure 3). The
effect of vitamin D on IL-1b gene expression has already been
demonstrated in primary mouse keratinocytes and other cell types,
whereas the induction of proteins involved in intracellular
trafficking has not previously been shown [39,40–42]. Rab20
was recently identified as a potential regulator of connexin 43
trafficking [43].
We then assessed the power of the selected genetic signatures to
classify samples treated with different reagents probing different
types of receptors. We treated DCs with live bacteria, such as
Listeria monocytogenes and Lactobacillus paracasei,1 0mM nimesulide
and 1000 U/ml IFNa to modify their functional state. As
expected, live bacteria induced the strongest inflammatory
Figure 1. PCA score plot. Seventy-nine ‘‘inflammatory’’ observations and 36 ‘‘non inflammatory’’ observations (listed in Table 1) used to generate
and test the random forest model. Genome-wide gene expression data were collected with DNA-microarray technology and the normalized
hybridization signals were analyzed by PCA. A score plot with the first and second principal component axes is shown. Inflamed samples are mostly
projected toward negative values of the first PC axis, whereas samples from controls and non inflamed samples are projected toward positive values.
INF: Inflamed samples; NINF: non-inflamed samples.
doi:10.1371/journal.pone.0009404.g001
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Affymetrix ID Gene Title Gene Symbol
100423_f_at SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5A STAT5A
100540_at LEUKOTRIENE A4 HYDROLASE LTA4H
100584_at ANNEXIN A4 ANXA4
100588_at PROTEASOME (PROSOME, MACROPAIN) 28 SUBUNIT, BETA PSME2
100779_at INTERLEUKIN 12B IL12B
100981_at INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1 IFIT1
101072_at EUKARYOTIC TRANSLATION INITIATION FACTOR 4E BINDING PROTEIN 2 EIF4EBP2
101144_at INTERLEUKIN 18 RECEPTOR 1 IL18R1
101995_at SEQUESTOSOME 1 SQSTM1
102218_at INTERLEUKIN 6 IL6
102310_at CHEMOKINE (C-C MOTIF) LIGAND 22 CCL22
102779_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 BETA GADD45B
102831_s_at CD86 ANTIGEN CD86
103035_at TRANSPORTER 1, ATP-BINDING CASSETTE, SUB-FAMILY B (MDR/TAP) TAP1
103040_at CD83 ANTIGEN CD83
103254_at TRAF TYPE ZINC FINGER DOMAIN CONTAINING 1 TRAFD1
103402_at TRANSMEMBRANE 7 SUPERFAMILY MEMBER 3 TM7SF3
103486_at INTERLEUKIN 1 BETA IL1B
103494_at TETRASPANIN 8 TSPAN8
103665_at ELOVL FAMILY MEMBER 6, ELONGATION OF LONG CHAIN FATTY ACIDS (YEAST) ELOVL6
104149_at NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B-CELLS INHIBITOR, ALPHA NFKBIA
104376_at HISTONE DEACETYLASE 5 HDAC5
104418_at ZINC AND RING FINGER 2 ZNRF2
104443_at CHEMOKINE (C-C MOTIF) RECEPTOR 7 CCR7
160501_at KINESIN FAMILY MEMBER 20A KIF20A
160608_at RAB20, MEMBER RAS ONCOGENE FAMILY RAB20
161005_at RIKEN CDNA 5730420B22 GENE TXNDC16
92962_at CD40 ANTIGEN CD40
93092_at HISTOCOMPATIBILITY 2, CLASS II, LOCUS DMA H2-DMA
93367_at TELOMERASE ASSOCIATED PROTEIN 1 TEP1
93448_at RIKEN CDNA E330036I19 GENE DAGLB
94186_at TNF RECEPTOR-ASSOCIATED FACTOR 1 TRAF1
94256_at CHLORIDE INTRACELLULAR CHANNEL 4 (MITOCHONDRIAL) CLIC4
94294_at CYCLIN B2 CCNB2
94501_at SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 1 SGPP1
94752_s_at SKI-LIKE SKIL
94814_at GUANINE NUCLEOTIDE BINDING PROTEIN, ALPHA INHIBITING 3 GNAI3
94881_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) CDKN1A
94928_at TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1B TNFRSF1B
95024_at UBIQUITIN SPECIFIC PEPTIDASE 18 USP18
96120_at DNAJ (HSP40) HOMOLOG, SUBFAMILY B, MEMBER 6 DNAJB6
96125_at FAS DEATH DOMAIN-ASSOCIATED PROTEIN DAXX
96319_at RIKEN CDNA 2310042N09 GENE CDC20
96515_at INTERLEUKIN 4 INDUCED 1 IL4I1
96752_at INTERCELLULAR ADHESION MOLECULE ICAM1
96935_at PDZK1 INTERACTING PROTEIN 1 PDZK1IP1
98002_at INTERFERON REGULATORY FACTOR 8 IRF8
98405_at SERINE (OR CYSTEINE) PEPTIDASE INHIBITOR, CLADE B, MEMBER 9 SERPINB9
98427_s_at NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B-CELLS 1, P105 NFKB1
98500_at INTERLEUKIN 1 RECEPTOR-LIKE 1 IL1RL1
Dendritic Cells Signatures
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Lactobacillus paracasei were correctly classified as inflammatory by
98% (53/54) and 94% (51/54) of the genes, respectively. Listeria
monocytogenes is known to induce the production of type I IFNs. We
therefore expected this bacterium to induce the interferon-
responsive genes Ifit1 and Isg15. Levels of transcription for Il1b,
Pdzk1ip1, Isg15, Ifit1 and Usp18 were strongly reduced by
Lactobacillus paracasei. We therefore conclude that Lactobacillus
paracasei is less able to induce a type I IFN response than other
genes of the inflammatory signature, suggesting that commensal
bacteria may specifically modulate inflammatory genes in DCs
(Figure 4A). Finally, we measured the effect of IFNa and
nimesulide treatment on DCs. We compared the results obtained
with nimesulide and IFNa with the signatures obtained with
dexamethasone, IL10 and vitamin D (Figure 4B). Nimesulide and
IFNa were classified as anti-inflammatory by 98% (53/54) and
80% (43/54) of the genes, respectively. Isg15, Ifit1, Usp18 are
known to be regulated by IFNa, whereas Clic4, Trafd1 and Il4i1
Affymetrix ID Gene Title Gene Symbol
98822_at INTERFERON, ALPHA-INDUCIBLE PROTEIN ISG15
98988_at NUCLEAR FACTOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B-CELLS INHIBITOR, ZETA NFKBIZ
99562_at MANNOSIDASE 2, ALPHA B1 MAN2B1
99982_at NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B-CELLS INHIBITOR, BETA NFKBIB
doi:10.1371/journal.pone.0009404.t002
Table 2. Cont.
Figure 2. Heat map of the dendritic cell-specific signature. Genes with different levels of expression in DCs treated with inflammatory stimuli
and in those treated with anti-inflammatory molecules. Each column represents a sample and each row represents a gene. Levels of gene expression
are indicated on a color scale, with red corresponding to the highest level of expression and blue corresponding to the lowest level. The Log2 ratio is
expressed with respect to the mean expression level of each gene.
doi:10.1371/journal.pone.0009404.g002
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role of IFNa in the regulation of DC activity [44,45].
We were able to classify samples treated with IFNa, Il10, vitamin
D as non inflammatory with this system, whereas live bacteria
(Listeria and Lactobacillus) were classified as inflammatory on the basis
of the strong inflammatory signatures induced. LPS and Poly I:C
were found to be stronger inducers of DC activation than zymosan
(46/54), at least in our experimental conditions. Zymosan has also
been shown to induce a regulatory phenotype in DCs [46].
Transcription Signatures Are Dendritic Cell-Specific
We assessed the specificity of the classifier genes by analyzing 44
of the 54 genes that gave consistent results for different samples by
qRT-PCR, in the macrophage cell line MT2 [47]. The MT2 cells
were stimulated with 10
28 M dexamethasone or 10 mg/ml LPS.
The genes of the inflammation signature were not well expressed
in MT2 cells if compared to the D1 cells (Figure 5). Only 41%
(18/44) of the genes showed the expected pattern of change in
expression in response to LPS stimulation in MT2 cells. Indeed,
Table 3. Upregulated genes are grouped functionally based on ontologies, and levels of significance are shown.
GO Biological Process N. of Genes % pValue Gene symbol Benjamini FDR
GO:0002376-immune system process 16 44,44 2,69E-11 Psme2, Nfkbia, Stat5a, IL1b, Tap1,
IL12b, Irf8, Ccl22, Sqstm1, Il6, Nfkb1,
CD40, Cdkn1a, Ifit1, Ccr7, Isg15
1,39E-07 5,13E-08
GO:0030154- cell differentiation 16 44,44 9,5E-07 Nfkbia, Skil, Traf1, Stat5a, Clic4,
Gadd45b, Il12b, Irf8, Tnfrsf1b,
Serpinb9, Sqstm1, Il6, Nfkb1,
Cd40, Cdkn1a, Daxx
1,23E-03 1,82E-03
GO:0008219- cell death 11 30,56 1,16E-06 Traf1, Stat5a, Sqstm1, Il6, Nfkb1,
Cd40, Cdkn1a, Gadd45b, Tnfrsf1b,
Serpinb9, Daxx
1,21E-03 2,23E-03
GO:0001816-cytokine production 6 16,67 3,86E-06 Stat5a, Il1b, Il6, Nfkb1, Cd40, Il12b 2,86E-03 7,37E-03
GO:0012501- programmed cell death 10 27,78 7,97E-06 Traf1, Stat5a, Sqstm1, Il6, Nfkb1,
Cd40, Cdkn1a, Gadd45b,
Serpinb9, Daxx
4,59E-03 1,52E-02
GO:0006954- inflammatory response 6 16,67 9,43E-05 Ccl22, Stat5a, Il1b, Il6, Nfkbiz, Tnfrsf1b 3,01E-02 1,80E-01
GO:0032502- developmental process 17 47,22 9,91E-05 Nfkbia, Skil, Traf1, Stat5a, Clic4,
Anxa4, Gadd45b, Il12b, Irf8,
Tnfrsf1b, Serpinb9, Sqstm1, Il6,
Nfkb1, Cd40, Cdkn1a, Daxx,
2,98E-02 1,89E-01
GO:0050789- regulation of
biological process
20 55,56 1,13E-04 Nfkbia, Traf1, Stat5a, Il1b, Clic4,
Nfkbiz, Icam1, Gadd45b, Il12b,
Irf8, Tnfrsf1b, Serpinb9, Dnajb6,
Sqstm1, Il6, Nfkb1, Cd40,
Cdkn1a, Daxx, Gnai3
3,21E-02 2,16E-01
GO:0050896- response to stimulus 17 47,22 4,73E-04 Nfkbia, Stat5a, Il1b, Nfkbiz,
Tap1, Il12b, Irf8, Tnfrsf1b,
Ccl22, Sqstm1, Il6, Cd86, Cd40,
Cdkn1a, Ifit1, Ccr7, Isg15
7,87E-02 9,01E-01
GO:0032020- ISG15 protein conjugation 2 5,56 1,03E-02 Usp18, Isg15 5,69E-01 1,80E+01
GO:0007154-cell communication 16 44,44 1,49E-02 Nfkbia, Traf1, Stat5a, Il1b, Rab20,
Gadd45b, Il12b, Tnfrsf1b, Ccl22,
Sqstm1, Il6, Nfkb1, Cd40, Ccr7,
Daxx, Gnai3
6,86E-01 2,49E+01
doi:10.1371/journal.pone.0009404.t003
Table 4. Downregulated genes are grouped functionally based on ontologies.
GO Biological Process N. of Genes % pValue Gene symbol Benjamini FDR
GO:0051301- cell division 3 16,67 2,45E-02 Ccnb2, Kif20a, Cdc20 1 37,754
GO:0006629- lipid metabolic process 4 22,22 2,57E-02 Daglb, Elovl6, Lta4h, Sgpp1 1 39,157
GO:defense response 4 22,22 3,36E-02 Hdac5, Il1rl1, Il18r1, Lta4h 1 47,956
GO:0008152- metabolic process 13 72,22 3,38E-02 Txndc16, Hdac5, Il1rl1, Daglb6, Lta4h,
Tep1, Sgpp1, H2-DMa, Eif4ebp2,
Man2b1, Elovl6, Znrf2, Cdc20
1 48,194
GO:0002376- immune system process 4 22,22 5,10E-02 Hdac5, H2-DMa, Il1rl1, Il18r1 1 63,237
GO:0045087- innate immune response 2 11,11 9,56E-02 Il1rl1, Il18r1 1 85,352
doi:10.1371/journal.pone.0009404.t004
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cell lines tested. Il18r1 was induced in MT2 cells but downreg-
ulated in DCs in response to LPS. We therefore conclude that the
inflammatory signature identified in this study is specific to DCs.
Classifier Genes Can Be Used to Predict the Inflammatory
Process in DCs In Vivo
Preclinical animal models of inflammation and infections have
become important tools for improving our understanding of the
regulation of inflammatory reactions in general and for the
development of novel treatment strategies to modulate excessive,
deleterious inflammatory reactions. We measured the gene
expression signature associated with inflammation in ex vivo splenic
DCs derived from mice treated with the endotoxin LPS, and
dexamethasone with the aim of converting our in vitro DC assay
into a useful tool for preclinical mouse models of inflammatory
diseases.
Splenic DCs detect antigens derived from the blood and are
widely used as a model system for testing treatments that affect DC
recruitment or for detecting DC activation during systemic
infection. We analyzed the pattern of expression of the 44 genes
in splenic DCs in vivo. We treated a group of mice with 50 mgo f
LPS/mouse or dexamethasone and, after 5 h, CD11c
+ cells were
purified from spleen by magnetic bead separation. Cell purity was
checked by FACS analysis and 90% of the cells were found to be
CD11c
+ (data not shown) then assessed the prognostic value of the
44 genes by qRT-PCR: 91% (40/44) and 80% (35/44) of the
genes correctly predicted the inflammatory or non inflammatory
Figure 3. Sample validation by quantitative real-time PCR. qRT-PCR confirmation of classifier transcript levels in inflamed samples derived
from DCs treated with TLR ligands (LPS, PolyI:C and zymosan) and in non inflamed samples treated with anti-inflammatory stimuli (dexamethasone,
vitamin D and IL-10) for 24 h. Reactions were performed in two wells, normalized to 18s rRNA levels. The results in the table are expressed relative to
the corresponding level of expression of each transcript in the untreated sample. Data are presented as mean fold changes in classifier gene
transcript levels in three independent experiments per group. The columns in the left reflect the pattern of expression as determined by microarray
analysis. NI: Non inflamed samples; INF; Inflamed samples.
doi:10.1371/journal.pone.0009404.g003
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signature selected in this study was also induced in DCs in vivo
(Figure 6 and Figure S3). We were unable to confirm the induction
of Il12b, Irf8 and Nfkb1 by LPS in vivo, possibly due to a lower
expression of these genes in vivo.
Discussion
The development and marketing of microarray platforms has
led to extensive investigation of global gene expression profiles in
health and disease. The expression profiling of diverse healthy
tissues provides a comprehensive view of the range of transcrip-
tional regulation in physiological conditions [43,48–50]. Similarly,
the identification of gene expression signatures indicative of disease
subtypes improves our understanding of the molecular basis of
disease [13,14,51]. Small sample size and the large number of
measurements required for each sample currently limit the efficacy
of gene expression profiling, leading to efforts to develop new
analytical methods. Gene expression profiles have recently found
applications in diagnosis, prognosis and the provision of predictive
information, and in the classification of human cancers and
inflammatory diseases [52,53].
In this study, we used the random forest algorithm [54] to
identify specific transcriptional signatures of inflammation in DCs
and to evaluate whether these molecular signatures could be used
to determine the activation state of DCs in vitro and in vivo.W e
found that the selected predictive genes upregulated during DCs
activation fell into distinct functional classes, with major
involvement in immune system processes (47%) cell differentiation
(44%), metabolic process (42%) and cell death (31%). Gene
Ontology analysis identified the genes involved in immune system
processes as Psme2, Cd40, Ccl22, Il1b, Sqstm1, Tap1, Il6, Il12b,
Ifit1, Ccr7, Irf8, Isg15, Nfkbia, Nfkb1, Stat5a and Cdkn1a. The
genes involved in cell differentiation identified were Nfkbia, Skil,
Traf1, Stat5a, Clic4, Gadd45b, Il12b, Irf8, Tnfrsf1b, Serpinb9,
Sqstm1, Il6, Nfkb1, Cd40, Cdkn1a and Daxx. Gene Ontology
analysis also identified genes involved in cell death, such as Traf1,
Stat5a, Sqstm1, Il6, Nfkb1, Cd40, Cdkn1a, Gadd45b, Tnfrsf1b,
Serpinb9 and Daxx. The downregulated predictive genes were
identified as involved in cell division (Ccnb2, Kif20a, Cdc20), lipid
metabolism (Daglb, Elovl6, Lta4h, Sgpp1), defense responses
(hdac5, Il1rl1, Il18r1, Lta4h) and metabolic processes (Txndc16,
Hdac5, Il1rl1, Daglb, Lta4h, Tep1, Sgpp1, H2-DMa, Eif4ebp2,
Man2b1, Elovl6, Znrf2, Cdc20).
Most of the genes selected showed a sustained up-regulation or
down-regulation suggesting that the processes they sustain, are
important throughout the maturation process. Nevertheless, to
deeply understand their functional role during DCs maturation,
knock down studies should be performed on one or more genes of
the signature.
Our findings clearly demonstrate that the gene expression
profiling of DCs reliably distinguishes between activating and non
activating stimuli. We validated our findings on an independent set
of samples treated with molecules inducing the activity of different
Figure 4. q-Real-time PCR analysis of gene expression on independent samples for class prediction. A) Expression levels of 54 genes in
DCs treated with the bacteria Listeria monocytogenes (Lm) and Lactobacillus paracasei (Lp) for 24 h. B) DC samples treated with nimesulide and IFNa
for 24 h. Comparison with cells treated with dexamethasone (DEX), IL-10 and vitamin D (VitD). Data are presented as mean fold changes in classifier
gene transcript levels in three independent experiments per group. NI: Non inflamed samples; INF; Inflamed samples.
doi:10.1371/journal.pone.0009404.g004
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were used as typical anti-inflammatory stimuli. They were
generally classified as non activating signals. By contrast, TLR
ligands and whole bacteria, which are widely recognized as
inflammatory signals, were classified as such by this system. The
signature expression profile identified here consists of 44 highly
predictive genes. These 44 genes provide a unique gene expression
profile indicative of activation in DCs and providing important
biological insight into the host response mediated by DCs. Genes
already identified as involved in inflammation and DC activation
were selected, including those encoding the interleukins Il6, Il12b
and Il1b [55], the chemokine Ccl22 [56], the membrane
molecules Cd40, Cd83, Cd86, Icam1, and Ccr7 and the
transcription factors Stat5a and Irf8, although the precise role of
Irf8 in DC activation is currently unknown.
Some of the genes selected have no known role in inflammation.
For example, the Pdzk1ip1 gene encodes a protein associated with
various tumors when abundant. This protein seems to play a role
in Akt activation and its gene was strongly induced by L.
monocytogenes and LPS, whereas no overexpression was associated
with poly I:C treatment. Thus, the induction of this gene is
dependent on surface TLR stimulation. Rab20 encodes a protein
Figure 5. Specificity of the genetic signature. Real-time PCR confirmation of 44 inflammatory signature genes in the DC line D1 and the absence
of this signature in MT2 cells. Both cell lines were treated with LPS (10 mg/ml) and 10
28 M dexamethasone (DEX) for 24 h. Data are presented as mean
fold changes in classifier gene transcript levels in three independent experiments per group.
doi:10.1371/journal.pone.0009404.g005
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role in inflammation. Rab20 has been shown to interact with
connexin 45 [43]. Il4i1 was recently identified as an oxidize active
against l-amino acids with potential effects on lymphocyte
proliferation. It is strongly induced by DC activation.
The genes encoding proteins involved in the NF-kB pathway
were more strongly induced by bacteria than TLR ligands.
Inhibitor genes, such as Nfkbia and Nfkbib, were also overex-
pressed after stimulation with bacteria, consistent with the
activation of regulatory mechanisms that control the inflamma-
tion. The downregulated genes include a large proportion of
membrane proteins, such as Il18r1, Il1rl1, Tspan8 and Tm7sf3,
and genes encoding proteins with enzymatic activity, such as
Man2b1 (an m-mannosidase), Lta4h (leukotriene A4 hydrolase),
Txndc16 (thioredoxin domain-containing 16), Sgpp1 (sphingosine-
1-phosphate phosphatase 1), Hdac5 (histone deacetylase 5). The
role of this dowregulation is currently unknown and requires
further investigation.
We used the dendritic cell line D1 to optimize the sensitivity and
precision of our gene expression profiling. We decided to
determine an inflammation signature for DCs rather than for
any other type of leukocyte, because DCs link innate and adaptive
Figure 6. In vivo validation of the DC-specific inflammatory signature. C57BL/6 mice were treated with LPS and, after 5 h, CD11c+ cells were
isolated and tested for the inflammatory signature. Data are presented as mean fold changes in classifier gene transcript levels in three independent
experiments.
doi:10.1371/journal.pone.0009404.g006
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of potential value for the testing of exogenous molecules with
potential anti-inflammatory or adjuvant activity in DCs, to favor
the repression or induction of T-cell responses. We validated the
inflammatory signature in vivo, by testing the response in splenic
DCs from mice treated with LPS and dexamethasone. Most of the
genes (80%) studied successfully characterized the activation state
of splenic DCs, and differentiated the profile of these cells from
that of DCs derived from mice treated with dexamethasone.
In conclusion, we used a meta-analysis of microarray data to
identify gene modules predictive of DC activation. Accuracy and
simplicity are essential characteristics of predictors for molecular
assays. The predictive accuracy of predictors generally ranges from
65% to 100% (mean, 82%) [58]. It is therefore important to
identify the best way to select a suitable classifier for data, to
maximize accuracy. In this study we used random forest methods
for the selection of genes and the classification of microarray data
[54,59]. The potential of array-based multidimensional predictors
to outperform traditional parameters is increasing for biomarker
discovery. The number of array-based studies is likely to increase
exponentially, particularly in the field of inflammatory diseases.
Such studies have been widely used for cancer classification
[60,61]. In this study, we identified and validated a prognostic
gene expression signature in DCs associated with inflammation.
The signaling events affected by many of the genes in this
signature occur in pathways essential for the immune response and
cell activation. These genes may therefore be suitable targets,
alone or in combination, for trials of anti-inflammatory and
adjuvant treatments. We have demonstrated that a genome-wide
systems biology approach may have advantages over traditional
methods for biomarker discovery. Moreover, the small number of
genes in our signature makes it possible to use simple, conventional
assays, such as quantitative reverse transcriptase-polymerase chain
reaction [62]. The increasing availability of laboratory diagnosis
by polymerase chain reaction has opened up new possibilities for
genomic testing based on the use of genetic signatures, in routine
clinical conditions.
Materials and Methods
Cell Culture
D1 cells [29] were maintained in vitro in Iscove’s modified
Dulbecco’s medium (IMDM, Euroclone) supplemented with 10%
heat-inactivated fetal bovine serum (Gibco, origin: Australia),
100 IU/ml penicillin, 100 mg/ml streptomycin, 2 mM L-gluta-
mine (all from Euroclone) and 50 mM b-mercaptoethanol (Sigma)
plus 30% R1 medium (supernatant from NIH3T3 fibroblasts
transfected with GM-CSF).
MT2 cells are immortalized macrophages. They were derived
from mouse thymus as previously described [47]. They were
cultured in IMDM (Euroclone) supplemented with 5% heat-
inactivated fetal bovine serum, 100 IU/ml penicillin, 100 mg/ml
streptomycin, 2 mM L-glutamine (all from Euroclone) and 50 mM
b-mercaptoethanol (Sigma).
Microarray Dataset
We obtained published gene expression datasets for microarray
experiments performed with D1 cells, dexamethasone (10
28 M),
the live microorganisms Schistosoma mansoni (MOI 1:200 parasites/
cell) and Leishmania mexicana (MOI 1:8) [23,30,31]. All the other
samples were prepared specifically for this study. D1 cells were
infected with Listeria monocytogenes EGD (MOI 1:20; provided by P.
Cossard, Pasteur Institute, France) or treated with various TLR
agonists: rLPS (10 mg/ml, Alexis, serotype R515), CpG (10 mg/ml,
Sigma), poly I:C (20 mg/ml, Amersham), Pam3Cys (1 mM, Sigma)
and zymosan (500 ng/ml, Sigma). In summary, the data set is
composed by: a) 14 untreated samples; b) 10 samples each of CpG,
Listeria monocytogenes, Pam3cis and polyI:C at time points 2 h, 4 h,
8 h, 12 h and 24 h in duplicates; c) 8 samples each of Leishmania
amastigote, Leishmania promastigote, Shistosoma SLA, Shistosoma EGGS
and LPS at the time points 4 h, 8 h, 12 h and 24 h in duplicates;
d) 6 samples of dexamethasone treated cells for the time points
4 h, 8 h and 24 h in duplicates; e) 15 zymosan treated samples at
time points 2 h, 4 h, 8 h, 12, and 24 h in triplicates. The data set
is composed in total of 115 microarrays.
Microarray Assay
We harvested 10
7 D1 cells in the immature state or after 4 h,
8 h, 12 h or 24 h of stimulation. Total RNA was isolated with
Trizol Reagent (Invitrogen, Life Technologies, Karlruhe, Ger-
many) and purified on a Qiagen RNeasy column (Qiagen, Hilden,
Germany) to remove small fragments. RNA quality was assessed
on an Agilent 2100 Bioanalyzer RNA 6000 Nano LabChip
(Agilent Technologies, Palo Alto, CA). Only samples with intact
total RNA profiles (retention of both ribosomal bands and the
broad central peak of mRNA) were used for the microarray and
quantitative RT-PCR gene expression analyses. In vitro transcrip-
tion (IVT) products were generated and oligonucleotide array
hybridization and scanning were carried out according to the
instructions supplied by Affymetrix (Santa Clara, CA). We used 10
to 16 mg of total RNA from each sample and T7-linked oligo-dT
primers for first-strand cDNA synthesis. The fragmented biotiny-
lated cDNA (15 mg) was hybridized onto the MG-U74Av2
GeneChip (Affymetrix), using the recommended procedures for
prehybridization, hybridization, washing and staining with
streptavidin–phycoerythrin (SAPE).
Microarray Data Analysis and Supervised Class Prediction
Array images were analyzed with the RMA algorithm [33].
Samples displaying a signal ratio .3.0 for the b-actin and
GAPDH probe sets were considered to be poor-quality targets and
were excluded from the dataset.
The final dataset contained the results for 115 arrays (79 DC
samples subjected to pro-inflammatory stimuli and 36 samples
with anti-inflammatory reagents). A single log scale normalized
expression measure for each probe set was obtained from the low-
level data files (CEL files), by the robust multiarray analysis (RMA)
procedure [33]. The data were subjected to Z-score-based
transformation. A diagnostic model was obtained by applying
the random forest (RF) method to the training set [54]. The model
was based on 1000 bootstrap samples of the training set, with 1000
classification trees generated with a view to classifying cases as
‘‘inflammatory’’ and ‘‘not-inflammatory’’ on the basis of micro-
array gene expression measurements. RF is a method of the
‘‘decision tree classifiers’’ family, but it works on a collection of
trees (a ‘forest’) rather than a single tree. In a decision tree, each
node represents an attribute — in our case, the probeset — and
the terminal nodes (the ‘leaves’) represent the attribute producing
the best separation between the classes –(‘‘inflammatory’’ and ‘‘not
inflammatory’’ in this analysis) of a dataset. RF feeds each tree
with an independent subset of attributes from a training set and
individual instances are classified by a voting procedure, with the
majority of the decision trees in the collection indicating the
appropriate classification. Finally, during the classification process,
RF determines the relative importance of each attribute, through
various methods, such as calculation of the Gini Index, which
assesses the importance of the variable and carries out accurate
variable selection.
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D1 cells were infected with Listeria monocytogenes EGD (multi-
plicities of infection, MOI, 1:20) and Lactobacillus paracasei (MOI
1:1000) or were treated with various stimuli: sLPS (10 mg/ml,
Alexis, serotype SO55:B5), poly I:C (20 mg/ml, Amersham),
zymosan (500 ng/ml, Sigma), dexamethasone (10
28 M, Sigma),
vitamin D (10
28 M, Sigma), IL-10 (50 ng/ml, Immunok), IFNa
(1000 U/ml, PBL Biomedical Laboratories) and Nimesulide
(10 mM, Cayman).
We harvested 5610
6 D1 cells either at 0 h or after 24 h of
stimulation. Total RNA was isolated with Trizol Reagent
(Invitrogen) and purified on a Qiagen RNeasy column (Mini kit,
Qiagen). DNase digestion was carried out in the column during
RNA extraction (RNase-free DNase Set, Qiagen). RNA quantity
and quality was evaluated spectrophotometrically (NanoDrop ND-
1000 Spectrophotometer, Thermo Scientific). We reverse tran-
scribed 1 mg of total RNA with random primers (High Capacity
cDNA Reverse Transcription Kit, Applied Biosystems). Quanti-
tative RT-PCR (qRT-PCR) was performed on 10 ng of total
cDNA from independent samples, using primer sets specific for 54
selected genes and the 18s housekeeping gene. qRT-PCR was
carried out on a 7500 machine (Applied Biosystems), with Power
SYBR Green PCR Master Mix (Applied Biosystems). Assays were
carried out in duplicate. Primers were designed with Primer3
software (http://frodo.wi.mit.edu/) and checked with other tools
(BLAST, http://blast.ncbi.nlm.nih.gov/Blast.cgi; m-fold, http://
mfold.bioinfo.rpi.edu/cgi-bin/dna-form1.cgi; IDT oligo analy-
zer,http://eu.idtdna.com/analyzer/Applications/OligoAnalyzer/
). Primers were validated, and only primers with an amplification
efficiency of 85 to 115% were accepted (Primm srl, Italy). Primer
sequences are reported in Figure S4. The raw data (Ct, threshold
cycle) were obtained with Applied Biosystems software. Relative
mRNA levels were calculated by the 2
2DDCt method (DCt =
Cttarget2Ct18s, DDCt = DCtstimulated 2 DCtnot treated), using 18s as
the housekeeping gene.
In Vivo Experiment
Three mice per group of six-week-old C57BL/6 were injected
with rLPS (50 mg/mouse, Alexis, serotype R515), dexamethasone
(50 mg/mouse, Sigma), or with PBS as a control. The spleen was
removed five hours later, and CD11c
+ cells (DCs) were purified by
magnetic bead separation (Miltenyi Biotec). C57BL/6 mice were
purchased from Charles River and were maintained in our animal
facility at the University of Milano-Bicocca. The in vivo experiment
has been repeated two times. All experiments were performed
using protocols approved by University of Milano-Bicocca Animal
Care and Use Committee. Mice were housed in containment
facilities of the animal facility and maintained on a regular
12:12 hour light:dark cycle with food and water ad libitum.
Supporting Information
Figure S1 Training and test sets, as used for the development of
a classifier for the predictive analysis of microarrays. All samples
were chosen based on the stimulus used for DC activation. The
classifier, the random forest, was developed on the basis of two
thirds of the samples (77 samples) and was then validated on the
remaining one third (38 samples).
Found at: doi:10.1371/journal.pone.0009404.s001 (0.36 MB TIF)
Figure S2 Selection of genes discriminating between DC
phenotypes. A) We investigated the predictive value of genes by
calculating the median level of expression for the gene in the
inflamed and non inflamed samples (LPS, PolyI:C, zymosan,
dexamethasone, IL-10 and vitamin D) and then calculating mean
expression levels for that gene. B-C) These values were used to
assess whether, for a particular stimulus (Listeria monocytogenes,
Lactobacillus paracasei, nimesulide or IFNI ˆ6), the expression
level of the gene concerned could be used to assign the sample to
the correct class. A score of 1 was assigned if the expression level
exceeded the mean value for inflammatory treatment or was below
the mean level for anti-inflammatory treatment. A score of 0 was
assigned in all other cases.
Found at: doi:10.1371/journal.pone.0009404.s002 (10.47 MB
TIF)
Figure S3 Selection of genes discriminating between different
DC phenotypes in vitro and in vivo. Class predictor genes were
identified on the basis of their mean levels of expression with
known stimuli and their classification performance was determined
in MT2 cells (A) and in ex vivo CD11c+ cells derived from the
spleens of mice treated with LPS (B).
Found at: doi:10.1371/journal.pone.0009404.s003 (1.16 MB TIF)
Figure S4 Primer sequences of house keeping and 54 genes
used.
Found at: doi:10.1371/journal.pone.0009404.s004 (0.03 MB
XLS)
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